Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979437250> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2979437250 endingPage "326" @default.
- W2979437250 startingPage "315" @default.
- W2979437250 abstract "Abstract As of September 10, 2019, there were 75 medications (oral/injectable/inhalants) approved by the U.S. Food and Drug Administration for diabetes management: 1 inhalant, 21 oral combinations, 22 injectable, and 31 oral medications (not in combination with any other diabetes drug). This article isolates the auditory and vestibular side effects of those drugs as reported by the drug's manufacturer as well as those side effects that could interfere with a balance assessment. Twenty of the 75 approved medications (26%) could have an auditory-related side effect. Hearing loss and tinnitus are not on the list. Only two, or just 3%, have vertigo and spinning as reported side effects (one each). More than 50% of the drugs will have some effect on a balance assessment. Audiologists who evaluate a patient with diabetes (PWD) are presented with symptoms that could be related to their diabetes medication. Although the manufacturer might report a side effect as rare or as a percentage from their clinical trials subjects, not all PWD will experience these adverse events. Auditory and vestibular side effects do not dominate the diabetes drug side effect list, but, rather, the most reported side effects could impact a balance assessment. The lists that appear in Appendices A and B should serve as a guide for all professionals involved in managing the PWD (i.e., audiologists, otolaryngologists, diabetes educators, pharmacists, optometrists, dentists, etc.). The list also serves as a counseling tool if a communication problem emerges during the progression of the diabetes." @default.
- W2979437250 created "2019-10-18" @default.
- W2979437250 creator A5047411220 @default.
- W2979437250 creator A5078764979 @default.
- W2979437250 date "2019-10-09" @default.
- W2979437250 modified "2023-09-23" @default.
- W2979437250 title "Auditory and Vestibular Side Effects of FDA-Approved Drugs for Diabetes" @default.
- W2979437250 cites W1635212197 @default.
- W2979437250 cites W1992479908 @default.
- W2979437250 cites W2041652400 @default.
- W2979437250 cites W2709177359 @default.
- W2979437250 cites W133614922 @default.
- W2979437250 doi "https://doi.org/10.1055/s-0039-1697645" @default.
- W2979437250 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6785333" @default.
- W2979437250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31602095" @default.
- W2979437250 hasPublicationYear "2019" @default.
- W2979437250 type Work @default.
- W2979437250 sameAs 2979437250 @default.
- W2979437250 citedByCount "4" @default.
- W2979437250 countsByYear W29794372502021 @default.
- W2979437250 countsByYear W29794372502022 @default.
- W2979437250 crossrefType "journal-article" @default.
- W2979437250 hasAuthorship W2979437250A5047411220 @default.
- W2979437250 hasAuthorship W2979437250A5078764979 @default.
- W2979437250 hasBestOaLocation W29794372502 @default.
- W2979437250 hasConcept C134018914 @default.
- W2979437250 hasConcept C141071460 @default.
- W2979437250 hasConcept C177713679 @default.
- W2979437250 hasConcept C190041318 @default.
- W2979437250 hasConcept C197934379 @default.
- W2979437250 hasConcept C199360897 @default.
- W2979437250 hasConcept C2776992516 @default.
- W2979437250 hasConcept C2779135839 @default.
- W2979437250 hasConcept C2780035454 @default.
- W2979437250 hasConcept C2780493683 @default.
- W2979437250 hasConcept C3454156 @default.
- W2979437250 hasConcept C41008148 @default.
- W2979437250 hasConcept C548259974 @default.
- W2979437250 hasConcept C555293320 @default.
- W2979437250 hasConcept C71924100 @default.
- W2979437250 hasConcept C98274493 @default.
- W2979437250 hasConceptScore W2979437250C134018914 @default.
- W2979437250 hasConceptScore W2979437250C141071460 @default.
- W2979437250 hasConceptScore W2979437250C177713679 @default.
- W2979437250 hasConceptScore W2979437250C190041318 @default.
- W2979437250 hasConceptScore W2979437250C197934379 @default.
- W2979437250 hasConceptScore W2979437250C199360897 @default.
- W2979437250 hasConceptScore W2979437250C2776992516 @default.
- W2979437250 hasConceptScore W2979437250C2779135839 @default.
- W2979437250 hasConceptScore W2979437250C2780035454 @default.
- W2979437250 hasConceptScore W2979437250C2780493683 @default.
- W2979437250 hasConceptScore W2979437250C3454156 @default.
- W2979437250 hasConceptScore W2979437250C41008148 @default.
- W2979437250 hasConceptScore W2979437250C548259974 @default.
- W2979437250 hasConceptScore W2979437250C555293320 @default.
- W2979437250 hasConceptScore W2979437250C71924100 @default.
- W2979437250 hasConceptScore W2979437250C98274493 @default.
- W2979437250 hasIssue "04" @default.
- W2979437250 hasLocation W29794372501 @default.
- W2979437250 hasLocation W29794372502 @default.
- W2979437250 hasLocation W29794372503 @default.
- W2979437250 hasOpenAccess W2979437250 @default.
- W2979437250 hasPrimaryLocation W29794372501 @default.
- W2979437250 hasRelatedWork W1528981156 @default.
- W2979437250 hasRelatedWork W177966395 @default.
- W2979437250 hasRelatedWork W2000142823 @default.
- W2979437250 hasRelatedWork W2314323655 @default.
- W2979437250 hasRelatedWork W2319869688 @default.
- W2979437250 hasRelatedWork W2394653553 @default.
- W2979437250 hasRelatedWork W2887029509 @default.
- W2979437250 hasRelatedWork W3169617370 @default.
- W2979437250 hasRelatedWork W3205519836 @default.
- W2979437250 hasRelatedWork W4312935407 @default.
- W2979437250 hasVolume "40" @default.
- W2979437250 isParatext "false" @default.
- W2979437250 isRetracted "false" @default.
- W2979437250 magId "2979437250" @default.
- W2979437250 workType "article" @default.